Sky News
@skynews·9.3M subscribers·76.1K videos
Replay: Could Ozempic save you from a heart attack?
Posted
December 27, 2024
Views
1,892
Likes
22
Comments
6
Engagement
1.48%
December 27, 2024
1,892
22
6
1.48%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
19:31Now PlayingWhile the Sky News Daily is on a Christmas break, we're replaying you some of the most memorable episodes we recorded in 2024 - starting with Ozempic.
Anti-obesity jabs like Ozempic could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug.
Researchers found after three years of treatment participants had a 20% lower risk of obesity and its associated health impacts, which currently cost the NHS more than £6bn each year.
On the Sky News Daily, Niall Paterson speaks to Sky's science and medical correspondent Thomas Moore about the implications of reducing heart disease cases for the NHS, and senior lecturer in physiology at Anglia Ruskin University Dr Simon Cork explains how the wonder-drug actually works.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
